In models of syngeneic melanoma and breast cancer, IFNγ commonly overexpressed in the tumoral microenvironment was shown to upregulate PDL1 on tumor associated LECs which consequently inhibited T cell mediated anti-tumor immunity (Dieterich et al., 2017). The gene discussed is CD274; the disease is breast cancer.